Oruka Therapeutics director Kristine M. Ball sells shares worth $1.89 million

ORKA•2026-11-14

Director Kristine M. Ball sold 18,000 Oruka Therapeutics common shares on Nov. 12, 2026, leaving no directly held common stock. She exercised 18,000 stock options at $6.84 per share and retained 53,426 directly held options.

Oruka Therapeutics director Kristine M. Ball sells shares worth $1.89 million

1. Share sale and options

Related News

Trinity Place Holdings Q3 net loss narrows 61% to $116,000; no revenue

Nasdaq halts trading in MBS pending news at 7:50 p.m.

indie Semiconductor director David J. Aldrich acquires $299,000 in common shares

Sources

Oruka Therapeutics director Kristine M. Ball sells shares worth $1.89 million

PubMatic CFO Steven Pantelick reports sale of common shares worth $935,551.70

Nasdaq trade halt continues, reason not available at 07:29 p.m.